Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Tatiana Smolonogina"'
Publikováno v:
Pharmaceuticals, Vol 15, Iss 5, p 498 (2022)
Humoral immunity to influenza neuraminidase (NA) was evaluated among different groups of people including patients with acute influenza infection and healthy people in different age groups using an enzyme linked lectin assay (ELLA). The amino acid co
Externí odkaz:
https://doaj.org/article/016aa39cb07a44669a0f7cb0d4c41fff
Publikováno v:
Antibodies, Vol 9, Iss 2, p 20 (2020)
Background: Currently, the immunogenicity of influenza vaccines is assessed by detecting an increase of hemagglutination inhibition (HI) antibodies. As neuraminidase (NA)-based immunity may be significant in protecting against influenza infection, de
Externí odkaz:
https://doaj.org/article/35f44269241f425ea6daeeb0c52f19d1
Autor:
Yulia Desheva, Ivan Sychev, Tatiana Smolonogina, Andrey Rekstin, Natalia Ilyushina, Vladimir Lugovtsev, Anastasia Samsonova, Aleksey Go, Anna Lerner
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0196771 (2018)
The main objective of the study was to evaluate neuraminidase inhibiting (NI) antibodies against A/H1N1pdm09 influenza viruses in the community as a whole and after infection. We evaluated NI serum antibodies against A/California/07/09(H1N1)pdm and A
Externí odkaz:
https://doaj.org/article/d6773be116284c9a83bf28b633dc5cd4
Autor:
Victoria Matyushenko, Irina Isakova-Sivak, Tatiana Smolonogina, Irina Dubrovina, Tatiana Tretiak, Larisa Rudenko
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180497 (2017)
Live attenuated influenza vaccines (LAIVs) are considered as safe and effective tool to control influenza in different age groups, especially in young children. An important part of the LAIV safety evaluation is the detection of vaccine virus replica
Externí odkaz:
https://doaj.org/article/188c348443934f4d8fd0c32e162dd980
Autor:
Irina Isakova-Sivak, Jørgen de Jonge, Tatiana Smolonogina, Andrey Rekstin, Geert van Amerongen, Harry van Dijken, Justin Mouthaan, Paul Roholl, Victoria Kuznetsova, Elena Doroshenko, Vadim Tsvetnitsky, Larisa Rudenko
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e102339 (2014)
H2N2 Influenza A caused the Asian flu pandemic in 1957, circulated for more than 10 years and disappeared from the human population after 1968. Given that people born after 1968 are naïve to H2N2, that the virus still circulates in wild birds and th
Externí odkaz:
https://doaj.org/article/8bf254488d9e4ae3bd4006388b2ae3d6
Autor:
Victoria Matyushenko, Tatiana Smolonogina, E. A. Stepanova, Alexander Suvorov, G. Leontieva, Larisa Rudenko, Svetlana Donina, Anastasia Matushkina, Irina Isakova-Sivak
Publikováno v:
Medical academic journal. 20:33-42
Group B streptococci (GBS) cause a number of serious diseases in humans. The development of an effective vaccine against GBS requires special approaches. In the present study, three recombinant influenza viruses were constructed on the backbone of H7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4edf6fabbe4fadbad9362f97e75df8cc
https://doi.org/10.17816/maj50307
https://doi.org/10.17816/maj50307
Autor:
E. A. Stepanova, Larisa Rudenko, A. S. Evsina, G. F. Leontieva, Irina Isakova-Sivak, Polina Prokopenko, Alexander Suvorov, Tatiana Kotomina, Tatiana Smolonogina
Publikováno v:
Molecular Genetics, Microbiology and Virology. 34:25-34
The aim of this study was to develop a cold-adapted influenza A (H7N9) strain-based vector vaccine expressing epitopes of conserved lipoprotein of Streptococcus agalactiae. Recombinant hemagglutinin (HA) genes of live attenuated influenza vaccine (LA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd3b71c2e797be0cd604479b69ba4c91
https://doi.org/10.3103/s0891416819010087
https://doi.org/10.3103/s0891416819010087
Publikováno v:
Antibodies
Volume 9
Issue 2
Antibodies, Vol 9, Iss 20, p 20 (2020)
Volume 9
Issue 2
Antibodies, Vol 9, Iss 20, p 20 (2020)
Background: Currently, the immunogenicity of influenza vaccines is assessed by detecting an increase of hemagglutination inhibition (HI) antibodies. As neuraminidase (NA)-based immunity may be significant in protecting against influenza infection, de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13d89ea5c5e8ac7aa6c82136fcc1bbf1
Autor:
Irina Isakova-Sivak, Larisa Rudenko, G. F. Leont’eva, E. A. Fedorova, Daniil Korenkov, Tatiana Kotomina, Tatiana Smolonogina, Alexander Suvorov
Publikováno v:
Bulletin of Experimental Biology and Medicine. 164:743-748
A project of an experimental recombinant vector vaccine for prevention of diseases caused by pathogenic streptococci based on ScaAB lipoprotein of Streptococcus agalactiae and a coldadapted strain of live influenza vaccine as a vector was developed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1f4e17d04dfd85ebb189eea15a23075
https://doi.org/10.1007/s10517-018-4071-4
https://doi.org/10.1007/s10517-018-4071-4
Autor:
Thi H. O. Nguyen, Irina Isakova-Sivak, Katherine Kedzierska, Tatiana Smolonogina, Daniil Korenkov, Lorena E. Brown, Larisa Rudenko
Publikováno v:
Human Vaccines & Immunotherapeutics. 14:941-946
Live attenuated influenza vaccines (LAIV) induce CD8+ T lymphocyte responses that play an important role in killing virus-infected cells. Despite the relative conservation of internal influenza A proteins, the epitopes recognized by T cells can under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c831e2608ca4258d638088424472ba8
https://doi.org/10.1080/21645515.2017.1417713
https://doi.org/10.1080/21645515.2017.1417713